Colorectal Cancer Treatment Concepts for Internal Me... | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Colorectal Cancer Treatment Concepts: Surgery to Surveillance [ Medical Education ](https://mdster.com/blog?category=medical-education) Colorectal Cancer Treatment Concepts: Surgery to Surveillance =============================================================== A board-focused, clinically practical review of how to think about surgery, adjuvant therapy, metastatic palliation, and post-resection follow-up in colorectal cancer. [ MDster Editorial Team ](https://mdster.com/about) · Mar 29, 2026 · 6 min read · 290 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Gastrointestinal Oncology ](https://mdster.com/blog?tag=gastrointestinal-oncology) [ Colorectal Cancer ](https://mdster.com/blog?tag=colorectal-cancer) [ Oncology Boards ](https://mdster.com/blog?tag=oncology-boards) [ Cancer Surveillance ](https://mdster.com/blog?tag=cancer-surveillance) ![Colorectal Cancer Treatment Concepts: Surgery to Surveillance](https://mdster.com/storage/blog/images/colorectal-cancer-treatment-concepts-surgery-to-surveillance.jpg) Share this article Share this post On this page 1. [ Start with treatment intent ](#start-with-treatment-intent) 2. [ Surgery and adjuvant therapy overview ](#surgery-and-adjuvant-therapy-overview) 3. [ Metastatic disease: palliative does not mean passive ](#metastatic-disease-palliative-does-not-mean-passive) 4. [ Surveillance after resection concepts ](#surveillance-after-resection-concepts) 5. [ Key Takeaways ](#key-takeaways) 6. [ Conclusion ](#conclusion) 7. [ References ](#references-heading) On this page 1. [ Start with treatment intent ](#start-with-treatment-intent) 2. [ Surgery and adjuvant therapy overview ](#surgery-and-adjuvant-therapy-overview) 3. [ Metastatic disease: palliative does not mean passive ](#metastatic-disease-palliative-does-not-mean-passive) 4. [ Surveillance after resection concepts ](#surveillance-after-resection-concepts) 5. [ Key Takeaways ](#key-takeaways) 6. [ Conclusion ](#conclusion) 7. [ References ](#references-heading) A patient with newly resected pT3N1 colon adenocarcinoma is recovering well, and the intern asks, “So we just watch now?” That question captures why **treatment concepts** matter. In colorectal cancer (CRC), the key decisions after diagnosis are not semantic; they define whether you are aiming for cure, relapse reduction, or palliation. For internists, this is everyday medicine: you will manage chemotherapy toxicity, iron deficiency, ostomy complications, VTE risk, and the surveillance plan long after the operation note is signed. [\[1\]](#cite-1 "Reference [1]") Start with treatment intent --------------------------- The first treatment question is not “colon or rectum?” It is **localized, potentially curable metastatic, or unresectable metastatic**. Localized **colon** cancer is usually surgery first. **Rectal** cancer is different: MRI staging drives management, and many higher-risk stage II/III cases now receive **total neoadjuvant therapy (TNT)** before any operation; selected complete responders may even discuss nonoperative management in expert programs. Always get **MMR/MSI status** early. That is not just genetics housekeeping: it helps identify Lynch syndrome and now directly changes treatment selection in rectal and metastatic disease. [\[2\]](#cite-2 "Reference [2]") SettingUsual backboneBoard trap**Colon cancer**Surgery first, then adjuvant therapy by pathologic riskForgetting that node count matters for staging**Rectal cancer**MRI-based planning; neoadjuvant/TNT common in locally advanced diseaseTreating it like “colon cancer lower down” That split is the one boards expect you to keep straight. [\[3\]](#cite-3 "Reference [3]") Surgery and adjuvant therapy overview ------------------------------------- For **colon cancer**, oncologic resection with adequate lymphadenectomy is the backbone, and **fewer than 12 lymph nodes examined** is itself a high-risk feature because it weakens staging confidence. **Stage III colon cancer** generally gets adjuvant chemotherapy unless frailty or competing risk overwhelms benefit; common platforms are **FOLFOX** or **CAPOX**, with duration individualized to recurrence risk and oxaliplatin neurotoxicity. **Stage II** is where learners overcall treatment. Do **not** give adjuvant therapy reflexively. Offer it clearly for **T4** tumors and consider it for other high-risk features such as fewer than 12 nodes, lymphovascular or perineural invasion, poor differentiation, obstruction, perforation, or marked tumor budding. The high-yield exception is **dMMR/MSI-H stage II disease**: do not routinely reach for fluoropyrimidine monotherapy there. [\[3\]](#cite-3 "Reference [3]") Hereditary syndromes belong in this discussion, even in an overview. If Lynch syndrome, FAP, or another inherited syndrome is suspected, do not treat surgery as a one-size-fits-all event. The extent of colectomy, surveillance of the remaining bowel, and cascade testing for relatives may all change. In practice, that means the internist should not ignore a young patient, synchronous tumors, heavy family history, or universal tumor testing that shows MMR deficiency. [\[4\]](#cite-4 "Reference [4]") > **Clinical Pearl:** In stage II colon cancer, the right question is not “chemo or no chemo?” It is “**which risk features are actually present, and is the tumor dMMR/MSI-H?**” That single pause prevents a lot of board errors. [\[3\]](#cite-3 "Reference [3]") Metastatic disease: palliative does not mean passive ---------------------------------------------------- Most metastatic CRC is treated with **palliative intent**, but never confuse palliative with nihilistic. The goals are to control symptoms, preserve performance status, prolong survival, and keep future lines open. For **initially unresectable** disease, first-line therapy is usually a **doublet**, with triplet therapy reserved for select fit patients. Biology then takes over: **MSI-H/dMMR metastatic CRC** belongs in the immunotherapy lane; **left-sided, RAS wild-type, MSS/pMMR** disease often favors chemotherapy plus an **anti-EGFR** agent; **right-sided** RAS wild-type disease more often pairs chemotherapy with **anti-VEGF** therapy. In previously treated disease, know the board pairings: **BRAF V600E** disease points to **encorafenib plus cetuximab**, and **KRAS G12C** disease now has approved anti-EGFR-based targeted combinations in refractory settings. Limited liver, lung, or selected peritoneal metastases deserve multidisciplinary review because some patients can still reach **curative-intent resection or ablative therapy**. [\[5\]](#cite-5 "Reference [5]") Do not wait until the last admission to involve palliative care. ASCO’s current guidance is clear: patients with advanced cancer should have **early specialty palliative care integrated alongside active oncologic treatment**, especially when symptoms, distress, or goals-of-care uncertainty are already present. That is good oncology and good internal medicine. [\[6\]](#cite-6 "Reference [6]") Surveillance after resection concepts ------------------------------------- Surveillance after curative-intent resection is not clerical follow-up; it is part of treatment. The aim is to detect **salvageable recurrence** and **metachronous neoplasia** while the patient still has options. A common framework is front-loaded follow-up for five years: history/physical and **CEA** at regular intervals early on, periodic **CT chest/abdomen/pelvis**, and **colonoscopy at 1 year** after surgery (or after the perioperative clearing exam), then usually at **3 years** and then every **5 years** if normal. Rectal cancer may need additional local surveillance depending on surgical technique and local recurrence risk. Two exam traps matter: do **not** substitute **FIT/fecal DNA** for post-resection surveillance, and do not order routine blood panels as if they are validated recurrence tests. Keep the program purposeful. [\[7\]](#cite-7 "Reference [7]") Key Takeaways ------------- - Classify CRC by **treatment intent** first: localized, potentially curable metastatic, or unresectable metastatic. [\[2\]](#cite-2 "Reference [2]") - **Stage III colon cancer** usually gets adjuvant chemotherapy; **stage II** gets it selectively, and **dMMR/MSI-H stage II** is the classic exception. [\[3\]](#cite-3 "Reference [3]") - **Rectal cancer is not colon cancer in a tighter space**; TNT now shapes many locally advanced rectal cases. [\[2\]](#cite-2 "Reference [2]") - In metastatic disease, choose therapy by **MMR/MSI, RAS/BRAF status, sidedness, symptoms, and resectability**. [\[5\]](#cite-5 "Reference [5]") - After curative resection, remember the surveillance spine: **CEA/exam, periodic CT, colonoscopy at 1 year, then 3 years, then 5 years if normal**. [\[7\]](#cite-7 "Reference [7]") Conclusion ---------- If you remember one framework, make it this: **surgery treats the anatomy, adjuvant therapy treats microscopic risk, metastatic therapy follows tumor biology, and surveillance is active care—not an afterthought**. That mindset is high-yield for boards and safer for patients. [\[3\]](#cite-3 "Reference [3]") References (8) ------------------ 1. 1. [ National Cancer Institute. Colon Cancer Treatment (PDQ®)–Health Professional Version. ](https://www.cancer.gov/types/colorectal/hp/colon-treatment-pdq) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ Scott AJ, et al. Management of Locally Advanced Rectal Cancer: ASCO Guideline. J Clin Oncol. 2024. ](https://pubmed.ncbi.nlm.nih.gov/39116386/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ Baxter NN, et al. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. J Clin Oncol. 2022. ](https://pubmed.ncbi.nlm.nih.gov/34936379/) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ pubmed.ncbi.nlm.nih.gov/25452455 ](https://pubmed.ncbi.nlm.nih.gov/25452455/) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ Morris VK, et al. Treatment of Metastatic Colorectal Cancer: ASCO Guideline. J Clin Oncol. 2023. ](https://pubmed.ncbi.nlm.nih.gov/36252154/) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ Ferrell BR, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol. 2024. ](https://pubmed.ncbi.nlm.nih.gov/38748941/) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ www.cancercareontario.ca/sites/ccocancercare/files/derivative/SurvivorshipClinicalGuidanceCRC.pdf ](https://www.cancercareontario.ca/sites/ccocancercare/files/derivative/SurvivorshipClinicalGuidanceCRC.pdf) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ American Gastroenterological Association. Colonoscopy surveillance after colorectal cancer resection. ](https://gastro.org/clinical-guidance/colonoscopy-surveillance-after-colorectal-cancer-resection/) Next Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress [ Start practicing ](https://mdster.com/user/dashboard) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Gastrointestinal Oncology ](https://mdster.com/blog?tag=gastrointestinal-oncology) [ # Colorectal Cancer ](https://mdster.com/blog?tag=colorectal-cancer) [ # Oncology Boards ](https://mdster.com/blog?tag=oncology-boards) [ # Cancer Surveillance ](https://mdster.com/blog?tag=cancer-surveillance) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### BVM Ventilation: Indications and Preparation Before the First Breath 7 min read Oct 05, 2026 ](https://mdster.com/blog/bvm-ventilation-indications-and-preparation-before-the-first-breath) [### Memory Systems and Reconsolidation: Why Fear Returns After Exposure 6 min read Oct 04, 2026 ](https://mdster.com/blog/memory-systems-and-reconsolidation-why-fear-returns-after-exposure) [### Applying Guidelines to Individuals in Obstetrics and Gynecology 6 min read Oct 03, 2026 ](https://mdster.com/blog/applying-guidelines-to-individuals-in-obstetrics-and-gynecology) Related Posts ------------- [ ![BVM Ventilation: Indications and Preparation Before the First Breath](https://mdster.com/storage/blog/images/bvm-ventilation-indications-and-preparation-before-the-first-breath.png) Medical Education ### BVM Ventilation: Indications and Preparation Before the First Breath Before squeezing the bag, decide why ventilation is needed, position the patient, plan preoxygenation, and make suction and airway adjuncts immediately available. 7 min read 0 comments ](https://mdster.com/blog/bvm-ventilation-indications-and-preparation-before-the-first-breath) [ ![Diabetic Ketoacidosis Case Discussion: Insulin, Fluids, and the Transition](https://mdster.com/storage/blog/images/diabetic-ketoacidosis-case-discussion-insulin-fluids-and-the-transition.png) Case Discussion ### Diabetic Ketoacidosis Case Discussion: Insulin, Fluids, and the Transition Follow a DKA case from diagnosis through potassium replacement, dextrose, neurologic reassessment, and a safe return to subcutaneous insulin. 1 min read 0 comments ](https://mdster.com/blog/diabetic-ketoacidosis-case-discussion-insulin-fluids-and-the-transition) [ ![Memory Systems and Reconsolidation: Why Fear Returns After Exposure](https://mdster.com/storage/blog/images/memory-systems-and-reconsolidation-why-fear-returns-after-exposure.png) Medical Education ### Memory Systems and Reconsolidation: Why Fear Returns After Exposure Why can fear return after successful exposure therapy? Learn how emotional and contextual memory interact, what reconsolidation may change, and what the evidence supports in PTSD care. 6 min read 0 comments ](https://mdster.com/blog/memory-systems-and-reconsolidation-why-fear-returns-after-exposure) [ ![Applying Guidelines to Individuals in Obstetrics and Gynecology](https://mdster.com/storage/blog/images/applying-guidelines-to-individuals-in-obstetrics-and-gynecology.png) Medical Education ### Applying Guidelines to Individuals in Obstetrics and Gynecology Learn when an OB-GYN guideline fits the patient in front of you, how to reconcile conflicting recommendations, and how to make preference-sensitive decisions. 6 min read 0 comments ](https://mdster.com/blog/applying-guidelines-to-individuals-in-obstetrics-and-gynecology) [ Medical Education ### Breastfeeding Nipple Pain: Trauma, Thrush, or Dermatitis? A burning nipple is not automatically thrush. Learn to distinguish latch trauma, dermatitis, candidiasis, and vasospasm—and recognize when a breastfeeding dyad needs referral. 6 min read 0 comments ](https://mdster.com/blog/breastfeeding-nipple-pain-trauma-thrush-or-dermatitis) [ ![Nephrotic Syndrome: Managing Edema, Clot Risk, and Infection](https://mdster.com/storage/blog/images/nephrotic-syndrome-managing-edema-clot-risk-and-infection.png) Medical Education ### Nephrotic Syndrome: Managing Edema, Clot Risk, and Infection Nephrotic-range proteinuria is only the beginning. Learn how to assess edema, recognize thrombosis and infection, and avoid common management pitfalls. 5 min read 0 comments ](https://mdster.com/blog/nephrotic-syndrome-managing-edema-clot-risk-and-infection) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Curriculum](https://mdster.com/curriculum) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept